Karyn Jackson (right) helped Fernando Rico, of Pasadena, Calif., complete a Covered California application for health insurance at an enrollment fair in 2014. Allen J. Schaben/LA Times via Getty Images hide caption

toggle caption Allen J. Schaben/LA Times via Getty Images

Contractors who supply workers to farmers say requirements of the Affordable Care Act and the immigration status of many of the workers create a Catch-22. Maguey Images/Getty Images hide caption

toggle caption Maguey Images/Getty Images
Maria Fabrizio for NPR

Republican presidential hopeful Ted Cruz initially claimed his private insurance had been canceled. It turned out his insurer had transferred him to a plan with a narrow network of providers. Andrew Burton/Getty Images hide caption

toggle caption Andrew Burton/Getty Images

Multiple sclerosis pill Tecfidera is on the top 10 list of most costly specialty drugs, as measured by overall spending, for California's health benefit system for public workers and retirees. John/Flickr hide caption

toggle caption John/Flickr

Nancy Retzlaff, chief commercial officer for Turing Pharmaceuticals, was asked how much the drug Daraprim costs at the House Oversight and Government Reform Committee on Capitol Hill on Thursday. Brendan Smialowski/AFP/Getty Images hide caption

toggle caption Brendan Smialowski/AFP/Getty Images

Criminologist Joseph Richardson is skeptical that the federal government alone can solve the data problem for police shootings. "There has to be a more pioneering, innovative approach to doing it," he says. Spotmatik/iStockphoto hide caption

toggle caption Spotmatik/iStockphoto

"Instead of saying, 'We screwed up,' they said, 'Obamacare is the problem and we may not play anymore,' " Covered California's Peter Lee said of UnitedHealth. Rick Loomis/LA Times via Getty Images hide caption

toggle caption Rick Loomis/LA Times via Getty Images

Martin Shkreli was CEO of Turing Pharmaceuticals when the company boosted the price of a drug by 5,000 percent. He has since resigned. Paul Taggart/Bloomberg via Getty Images hide caption

toggle caption Paul Taggart/Bloomberg via Getty Images
Dana Neely/Corbis

NPR thanks our sponsors

Become an NPR sponsor